Choreo LLC Decreases Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Choreo LLC lowered its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 14.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,127 shares of the company's stock after selling 899 shares during the quarter. Choreo LLC's holdings in HCA Healthcare were worth $1,772,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in HCA. Norges Bank acquired a new position in HCA Healthcare in the fourth quarter valued at about $840,286,000. GAMMA Investing LLC boosted its position in HCA Healthcare by 40,527.3% in the first quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company's stock valued at $5,887,850,000 after buying an additional 1,699,713 shares in the last quarter. Barclays PLC boosted its position in HCA Healthcare by 85.7% in the fourth quarter. Barclays PLC now owns 1,061,891 shares of the company's stock valued at $318,727,000 after buying an additional 489,916 shares in the last quarter. Two Sigma Investments LP lifted its position in shares of HCA Healthcare by 12,016.0% during the fourth quarter. Two Sigma Investments LP now owns 467,437 shares of the company's stock worth $140,301,000 after purchasing an additional 463,579 shares in the last quarter. Finally, Metropolis Capital Ltd acquired a new position in shares of HCA Healthcare during the first quarter worth approximately $117,984,000. Institutional investors own 62.73% of the company's stock.

HCA Healthcare Trading Up 0.8%

Shares of NYSE:HCA traded up $2.59 during trading on Monday, reaching $336.91. The stock had a trading volume of 449,322 shares, compared to its average volume of 1,594,216. The firm's fifty day moving average is $373.81 and its 200 day moving average is $346.16. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The stock has a market cap of $81.05 billion, a price-to-earnings ratio of 14.12, a P/E/G ratio of 1.15 and a beta of 1.47.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. The company had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company's quarterly revenue was up 6.4% on a year-over-year basis. During the same period in the prior year, the firm posted $5.50 EPS. As a group, equities analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.85%. HCA Healthcare's dividend payout ratio (DPR) is 12.11%.

Insider Buying and Selling at HCA Healthcare

In related news, COO Jon M. Foster sold 15,698 shares of the firm's stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the transaction, the chief operating officer directly owned 12,646 shares of the company's stock, valued at $4,670,420.72. This trade represents a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 1.30% of the company's stock.

Analyst Ratings Changes

A number of brokerages have recently issued reports on HCA. Royal Bank Of Canada set a $401.00 target price on shares of HCA Healthcare and gave the stock an "outperform" rating in a research report on Monday. Morgan Stanley cut their price objective on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating on the stock in a report on Monday. Stephens upgraded shares of HCA Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Baird R W lowered shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Finally, Bank of America lowered shares of HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 price objective on the stock. in a report on Wednesday, July 16th. Nine research analysts have rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, HCA Healthcare currently has a consensus rating of "Moderate Buy" and a consensus target price of $396.46.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.